Filed: 8/14/2026ACC: 0002111609-26-000004
📋 What this filing means
ISHARA INVESTMENTS LP filed this quarterly 13F‑HR report disclosing 41 equity positions with a total reported market value of $136.10M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
41
Positions
$136.10M
Total AUM (reported)
9.97M
Total Shares
Allocation by class
COM$92.04M67.6%
COM NEW$20.71M15.2%
SPONSORED ADS$5.84M4.3%
COM PAR $.01$5.46M4.0%
CL A$3.80M2.8%
ADS$2.43M1.8%
SHS$2.22M1.6%
Portfolio Concentration
Top 3$28.33M20.8%
4–10$41.05M30.2%
11–25$49.23M36.2%
Rest$17.49M12.9%
Top 3 weight
20.8%
Top 10 weight
51.0%
Voting Authority Distribution
Total shares with voting rights: 9.97M
Sole
Full voting authority
9.97M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole41
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings41
Rows:
ACADIA PHARMACEUTICALS INC
SOLEShares410K
TypeSH
Market value$10.37M
7.62%
Sole
410K
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares1.23M
TypeSH
Market value$9.74M
7.16%
Sole
1.23M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares143.50K
TypeSH
Market value$8.21M
6.03%
Sole
143.50K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares22.55K
TypeSH
Market value$7.55M
5.55%
Sole
22.55K
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares205K
TypeSH
Market value$6.84M
5.03%
Sole
205K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares164K
TypeSH
Market value$6.09M
4.47%
Sole
164K
Shared
0.00
None
0.00
INSMED INC
SOLEShares51.25K
TypeSH
Market value$5.46M
4.01%
Sole
51.25K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares143.50K
TypeSH
Market value$5.37M
3.95%
Sole
143.50K
Shared
0.00
None
0.00
ZENTALIS PHARMACEUTICALS INC
SOLEShares1.02M
TypeSH
Market value$4.97M
3.65%
Sole
1.02M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares82K
TypeSH
Market value$4.77M
3.50%
Sole
82K
Shared
0.00
None
0.00
ANNEXON INC
SOLEShares820K
TypeSH
Market value$4.68M
3.44%
Sole
820K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares82K
TypeSH
Market value$4.66M
3.42%
Sole
82K
Shared
0.00
None
0.00
TONIX PHARMACEUTICALS HLDG C
SOLEShares338.25K
TypeSH
Market value$4.32M
3.17%
Sole
338.25K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares57.40K
TypeSH
Market value$4.28M
3.14%
Sole
57.40K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC.
SOLEShares16.40K
TypeSH
Market value$4.01M
2.95%
Sole
16.40K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares205K
TypeSH
Market value$3.36M
2.47%
Sole
205K
Shared
0.00
None
0.00
LEXICON PHARMACEUTICALS INC
SOLEShares1.27M
TypeSH
Market value$3.05M
2.24%
Sole
1.27M
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares276.75K
TypeSH
Market value$3.04M
2.23%
Sole
276.75K
Shared
0.00
None
0.00
DBV TECHNOLOGIES S A
SOLEShares184.50K
TypeSH
Market value$3.03M
2.22%
Sole
184.50K
Shared
0.00
None
0.00
GENMAB A/S
SOLEShares102.50K
TypeSH
Market value$2.82M
2.07%
Sole
102.50K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares32.80K
TypeSH
Market value$2.79M
2.05%
Sole
32.80K
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares102.50K
TypeSH
Market value$2.77M
2.03%
Sole
102.50K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares55.35K
TypeSH
Market value$2.43M
1.79%
Sole
55.35K
Shared
0.00
None
0.00
NUVATION BIO INC
SOLEShares369K
TypeSH
Market value$2.10M
1.54%
Sole
369K
Shared
0.00
None
0.00
WAVE LIFE SCIENCES LTD
SOLEShares328K
TypeSH
Market value$1.91M
1.40%
Sole
328K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ACADIA PHARMACEUTICALS INCSOLE | COM | 410K | SH | $10.37M 7.62% | 410K | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 1.23M | SH | $9.74M 7.16% | 1.23M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 143.50K | SH | $8.21M 6.03% | 143.50K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 22.55K | SH | $7.55M 5.55% | 22.55K | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 205K | SH | $6.84M 5.03% | 205K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 164K | SH | $6.09M 4.47% | 164K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 51.25K | SH | $5.46M 4.01% | 51.25K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 143.50K | SH | $5.37M 3.95% | 143.50K | 0.00 | 0.00 |
ZENTALIS PHARMACEUTICALS INCSOLE | COM | 1.02M | SH | $4.97M 3.65% | 1.02M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 82K | SH | $4.77M 3.50% | 82K | 0.00 | 0.00 |
ANNEXON INCSOLE | COM | 820K | SH | $4.68M 3.44% | 820K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 82K | SH | $4.66M 3.42% | 82K | 0.00 | 0.00 |
TONIX PHARMACEUTICALS HLDG CSOLE | COM NEW | 338.25K | SH | $4.32M 3.17% | 338.25K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 57.40K | SH | $4.28M 3.14% | 57.40K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INC.SOLE | COM | 16.40K | SH | $4.01M 2.95% | 16.40K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 205K | SH | $3.36M 2.47% | 205K | 0.00 | 0.00 |
LEXICON PHARMACEUTICALS INCSOLE | COM NEW | 1.27M | SH | $3.05M 2.24% | 1.27M | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 276.75K | SH | $3.04M 2.23% | 276.75K | 0.00 | 0.00 |
DBV TECHNOLOGIES S ASOLE | SPONSORED ADS | 184.50K | SH | $3.03M 2.22% | 184.50K | 0.00 | 0.00 |
GENMAB A/SSOLE | SPONSORED ADS | 102.50K | SH | $2.82M 2.07% | 102.50K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 32.80K | SH | $2.79M 2.05% | 32.80K | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 102.50K | SH | $2.77M 2.03% | 102.50K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 55.35K | SH | $2.43M 1.79% | 55.35K | 0.00 | 0.00 |
NUVATION BIO INCSOLE | COM CL A | 369K | SH | $2.10M 1.54% | 369K | 0.00 | 0.00 |
WAVE LIFE SCIENCES LTDSOLE | SHS | 328K | SH | $1.91M 1.40% | 328K | 0.00 | 0.00 |
Page 1 of 2